Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added the disease category Squamous cell carcinoma of the head and neck and introduced a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:11:21.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed. The update does not modify study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-19T04:59:00.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible content changes on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:02.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Page updated to Revision: v3.4.2 and the government funding status notice was removed; no study content or eligibility criteria were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:12:44.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Added a site-wide status notice about a lapse in government funding and the NIH Clinical Center’s operations, and updated the site version to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:53.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    New UI elements were added: a glossary toggle, a 'Last Update Submitted that Met QC Criteria' entry, a 'No FEAR Act Data' notice, and a revision tag showing v3.4.0. The prior items—'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision v3.3.4—were removed.
    Difference
    0.2%
    Check dated 2026-01-28T06:18:19.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.